Physician profile
April E Sandifer
NPI 1528229309
$600.06
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $84.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.86 | 2019-2020 | |
| Avanos Medical | $100.58 | 2019 | |
| Mylan Pharmaceuticals INC. | $51.75 | 2019 | |
| Merck Sharp & Dohme LLC | $39.53 | 2019 | |
| Roche Diagnostics Corporation | $29.49 | 2019 | |
| Duchesnay USA Incorporated | $20.49 | 2019 | |
| Hologic Sales and Service, LLC | $19.93 | 2020 | |
| Ethicon US, LLC | $18.45 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.65 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.55 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.39 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.78 | 2019 | |
| Millicent US INC | $12.70 | 2020 | |
| Minerva Surgical, INC | $11.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Sandifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.